Related Experiment Video
Updated: Jun 3, 2026
Induction and Diverse Assessment Indicators of Experimental Autoimmune Encephalomyelitis
Published on: September 9, 2022
Critical appraisal of animal models of multiple sclerosis
David Baker1, Wouter Gerritsen, Jon Rundle
1Neuroscience and Trauma Centre, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, UK. david.baker@qmul.ac.uk
Abstract:
Experimental autoimmune encephalomyelitis (EAE) is a spectrum of neurological disorders in laboratory animals that is used to model multiple sclerosis (MS). However, few agents have translated from efficacy in EAE to the treatment of human disease. Although this may reflect species differences in pathological disease mechanisms, importantly it may also relate to the practice of how drugs and models are currently used. This often bears very little resemblance to the clinical scenarios where treatments are investigated, such that lack of appreciation of the biology of disease may doom drugs to failure. The use of EAE is critically appraised with the aim of provoking thought, improving laboratory practise and aiding researchers and reviewers to address quality issues when undertaking, reporting and interpreting animal studies related to MS research. This is important as many researchers using EAE could and should do more to improve the quality of the studies.
Insights
Experimental autoimmune encephalomyelitis (EAE) models multiple sclerosis (MS) but few treatments translate. Improving EAE study quality is crucial for advancing MS research and drug development.
Area of Science:
- Neuroscience
- Immunology
- Translational Medicine
Background:
- Experimental autoimmune encephalomyelitis (EAE) is a widely used animal model for multiple sclerosis (MS).
- Despite extensive use, a significant gap exists between EAE efficacy and human clinical success for therapeutic agents.
- This discrepancy may stem from species-specific disease mechanisms and suboptimal alignment of preclinical study designs with clinical scenarios.
Purpose of the Study:
- To critically appraise the current use of EAE in multiple sclerosis research.
- To identify quality issues in the undertaking, reporting, and interpretation of EAE studies.
- To stimulate improved laboratory practices and enhance the translational value of EAE models.
Main Methods:
- Critical appraisal of existing literature and common practices in EAE research.
- Analysis of potential discrepancies between EAE models and human multiple sclerosis pathology.
- Review of methodologies and reporting standards in EAE studies.
Main Results:
- Current EAE study practices often lack resemblance to clinical settings, potentially dooming drug candidates.
- Appreciation of disease biology is frequently insufficient, impacting the interpretation of EAE results.
- Significant opportunities exist for researchers and reviewers to improve the quality of EAE studies.
Conclusions:
- Enhancing the quality and relevance of EAE studies is essential for successful translation to human multiple sclerosis treatment.
- Improved laboratory practices and critical appraisal are needed to maximize the utility of EAE as an MS model.
- Addressing methodological and reporting issues in EAE research will aid in the development of effective therapies for multiple sclerosis.
